Vascular endothelial growth factors and angiogenesis in eye disease.
about
Microphthalmia-associated transcription factor (MITF) promotes differentiation of human retinal pigment epithelium (RPE) by regulating microRNAs-204/211 expressionTherapeutic targets in age-related macular diseaseChordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesisRelationship between Oxidative Stress, Circadian Rhythms, and AMDFucoidan as a Potential Therapeutic for Major Blinding Diseases--A HypothesisCorneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapyMolecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targetsA review of anti-VEGF agents for proliferative diabetic retinopathyInhibition of oxygen-induced ischemic retinal neovascularization with adenoviral 15-lipoxygenase-1 gene transfer via up-regulation of PPAR-γ and down-regulation of VEGFR-2 expressionCytotoxic effects of curcumin in human retinal pigment epithelial cellssFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In VivoVascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy.EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro.Changes in the retina in induced hypoestrogenia (according to optical coherent tomography data).The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathyPigment epithelium-derived factor gene polymorphisms in exudative age-related degeneration in a chinese cohort.Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.Emerging biological therapies for age-related macula degeneration.Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out miceIncreased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferationActivation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.Clinical efficacy of intravitreal ranibizumab in early and mid-idiopathic choroidal neovascularizationMaintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathyVEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.Active HIF-1 in the normal human retinaGFAP-driven GFP expression in activated mouse Müller glial cells aligning retinal blood vessels following intravitreal injection of AAV2/6 vectorsExtracellular matrix nitration alters growth factor release and activates bioactive complement in human retinal pigment epithelial cellsEffects of bevacizumab on endoplasmic reticulum stress in hypoxic retinal pigment epithelial cells.Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo.Aberrant expression of genes and proteins in pterygium and their implications in the pathogenesisVascular endothelial growth factor in the circulation in cancer patients may not be a relevant biomarkerPEDF regulates vascular permeability by a γ-secretase-mediated pathway.Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization.Caspase-14 expression impairs retinal pigment epithelium barrier function: potential role in diabetic macular edemaThe retinal pigment epithelium in health and disease
P2860
Q24316369-3378CCCB-A170-416A-8607-01D3086F94D9Q24623107-FE23A9BA-B567-46A8-BBC8-B9CCA1132285Q24652148-60794A79-96DF-415F-8EA9-63EFF4A98AF0Q26765278-CEFCC257-F196-4F5E-8B51-13FDE6996B20Q26768638-FC40D734-19AC-4184-9915-9A36CBC0D1C7Q26823757-B6ECE342-DEDE-4CE7-AE31-B61B490C1C4FQ26865091-EADAAE8D-537F-4406-A9B7-150431AE597AQ27014620-05F4B012-75AD-4AA7-B003-46632D8DD9EDQ27025643-439F3B0A-B830-440E-8AE1-EBA513E00018Q27332433-EF753BF2-FDCD-40F6-A6E2-110A006630E3Q28488956-3E387C4D-F45B-43A4-B8DE-AA0C790DE130Q28552652-1C8C8824-7D61-4E6C-B422-ADA0D7F5DF66Q30244247-B082B187-A1D0-4BB8-8D23-4A772594CE65Q30490563-361533D8-09D4-47F6-9000-45D1114FA7F2Q30539235-0CFD2C05-E13A-42CE-A2C6-713C499F9B0AQ30704121-3A1B014F-3929-49FC-B410-5971BD899072Q30845192-4D23EDFE-A235-44B1-A813-71011CCD6420Q30993369-D53DBE74-DB87-45AB-B3DC-509666E1B880Q33209039-84FD9A51-988D-4C5C-A928-9E41E2EF39A1Q33224360-3C268A0A-7497-4FAF-9F59-4A9620241F7DQ33290573-4153A172-5219-4E78-877B-C5A079CF7CF2Q33518352-11A5AE2D-58FF-47ED-858E-C5049EF062D4Q33560677-A87D8FF5-411A-4EA0-A8A1-067B8F4E5DF0Q33607529-5589FA7A-024B-481C-B49D-C81E49341F4DQ33623966-DBD33C7F-CED7-4815-8FEC-0F9C4F9BC2ACQ33640270-939F7409-D11A-4C51-86C0-B7CC1E07DAF2Q33673946-D300A8A0-3773-40C7-A67A-FE7D262735B2Q33680151-9F245A26-CF14-42A6-B4E5-3C79E28A94D7Q33688281-31FDF3A0-E089-4D49-9307-C81E93784F3CQ33773175-4DF86557-054B-4FD1-AD51-4828A10E12FAQ33787955-A56F4135-2E18-402C-BC91-26C9247CF7C7Q33791749-9323B3D1-0909-4373-AEEB-9D8A525BD8E8Q33834038-8E59BB5A-4DC2-40A0-8181-E6F76F7A352CQ33840832-2CE632D8-AF1F-49C8-B88C-E54904BFD736Q33914637-241477E8-0D87-44A7-B8E8-0AD7B321B526Q33920807-92603A82-180B-4B33-8309-094EA888F474Q33939170-89146E55-745F-4A3F-B3C7-459968BCA8CCQ33960351-A574D168-D83A-4A7F-8B74-43C816707A48Q33993959-8AA12335-DF0E-40F0-9359-9751F2A344BEQ33998365-6AEC13D5-7F5B-43A9-82FD-BF42E7FF40EF
P2860
Vascular endothelial growth factors and angiogenesis in eye disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Vascular endothelial growth factors and angiogenesis in eye disease.
@ast
Vascular endothelial growth factors and angiogenesis in eye disease.
@en
type
label
Vascular endothelial growth factors and angiogenesis in eye disease.
@ast
Vascular endothelial growth factors and angiogenesis in eye disease.
@en
prefLabel
Vascular endothelial growth factors and angiogenesis in eye disease.
@ast
Vascular endothelial growth factors and angiogenesis in eye disease.
@en
P2093
P1476
Vascular endothelial growth factors and angiogenesis in eye disease.
@en
P2093
Schlingemann RO
Van Noorden CJ
Vrensen GF
P356
10.1016/S1350-9462(02)00043-5
P577
2003-01-01T00:00:00Z